Literature DB >> 23264618

Disulfide scrambling describes the oligomer formation of superoxide dismutase (SOD1) proteins in the familial form of amyotrophic lateral sclerosis.

Keisuke Toichi1, Koji Yamanaka, Yoshiaki Furukawa.   

Abstract

Dominant mutations in Cu,Zn-superoxide dismutase (SOD1) are a cause of a familial form of amyotrophic lateral sclerosis. Wild-type SOD1 forms a highly conserved intra-molecular disulfide bond, whereas pathological SOD1 proteins are cross-linked via intermolecular disulfide bonds and form insoluble oligomers. A thiol-disulfide status in SOD1 will thus play a regulatory role in determining its folding/misfolding pathways; however, it remains unknown how pathogenic mutations in SOD1 affect the thiol-disulfide status to facilitate the protein misfolding. Here, we show that the structural destabilization of SOD1 scrambles a disulfide bond among four Cys residues in an SOD1 molecule. The disulfide scrambling produces SOD1 monomers with distinct electrophoretic mobility and also reproduces the formation of disulfide-linked oligomers. We have also found that the familial form of amyotrophic lateral sclerosis-causing mutations facilitate the disulfide scrambling in SOD1. Based upon our results, therefore, scrambling of the conserved disulfide bond will be a key event to cause the pathological changes in disease-associated mutant SOD1 proteins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23264618      PMCID: PMC3576100          DOI: 10.1074/jbc.M112.414235

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model mice.

Authors:  Yoshiaki Furukawa; Ronggen Fu; Han-Xiang Deng; Teepu Siddique; Thomas V O'Halloran
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

2.  Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria.

Authors:  Han-Xiang Deng; Yong Shi; Yoshiaki Furukawa; Hong Zhai; Ronggen Fu; Erdong Liu; George H Gorrie; Mohammad S Khan; Wu-Yen Hung; Eileen H Bigio; Thomas Lukas; Mauro C Dal Canto; Thomas V O'Halloran; Teepu Siddique
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

3.  Impaired post-translational folding of familial ALS-linked Cu, Zn superoxide dismutase mutants.

Authors:  Cami K Bruns; Ron R Kopito
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

4.  Cysteine 111 affects aggregation and cytotoxicity of mutant Cu,Zn-superoxide dismutase associated with familial amyotrophic lateral sclerosis.

Authors:  Mauro Cozzolino; Ilaria Amori; Maria Grazia Pesaresi; Alberto Ferri; Monica Nencini; Maria Teresa Carrì
Journal:  J Biol Chem       Date:  2007-11-15       Impact factor: 5.157

5.  Oxidative modification to cysteine sulfonic acid of Cys111 in human copper-zinc superoxide dismutase.

Authors:  Noriko Fujiwara; Miyako Nakano; Shinsuke Kato; Daisaku Yoshihara; Tomomi Ookawara; Hironobu Eguchi; Naoyuki Taniguchi; Keiichiro Suzuki
Journal:  J Biol Chem       Date:  2007-10-03       Impact factor: 5.157

6.  Disulfide bond mediates aggregation, toxicity, and ubiquitylation of familial amyotrophic lateral sclerosis-linked mutant SOD1.

Authors:  Jun-ichi Niwa; Shin-ichi Yamada; Shinsuke Ishigaki; Jun Sone; Miho Takahashi; Masahisa Katsuno; Fumiaki Tanaka; Manabu Doyu; Gen Sobue
Journal:  J Biol Chem       Date:  2007-07-31       Impact factor: 5.157

7.  Structural and dynamic aspects related to oligomerization of apo SOD1 and its mutants.

Authors:  Lucia Banci; Ivano Bertini; Mirela Boca; Vito Calderone; Francesca Cantini; Stefania Girotto; Miguela Vieru
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-14       Impact factor: 11.205

8.  A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis.

Authors:  Celeste M Karch; David R Borchelt
Journal:  J Biol Chem       Date:  2008-03-03       Impact factor: 5.157

9.  Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis.

Authors:  Yoshiaki Furukawa; Kumi Kaneko; Koji Yamanaka; Thomas V O'Halloran; Nobuyuki Nukina
Journal:  J Biol Chem       Date:  2008-06-13       Impact factor: 5.157

10.  Initiation and elongation in fibrillation of ALS-linked superoxide dismutase.

Authors:  Madhuri Chattopadhyay; Armando Durazo; Se Hui Sohn; Cynthia D Strong; Edith B Gralla; Julian P Whitelegge; Joan Selverstone Valentine
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-20       Impact factor: 11.205

View more
  25 in total

1.  Structural basis of Cu, Zn-superoxide dismutase amyloid fibril formation involves interaction of multiple peptide core regions.

Authors:  Masataka Ida; Mizuho Ando; Masayuki Adachi; Asumi Tanaka; Kodai Machida; Kunihiro Hongo; Tomohiro Mizobata; Miho Yoshida Yamakawa; Yasuhiro Watanabe; Kenji Nakashima; Yasushi Kawata
Journal:  J Biochem       Date:  2015-08-29       Impact factor: 3.387

2.  A misfolded dimer of Cu/Zn-superoxide dismutase leading to pathological oligomerization in amyotrophic lateral sclerosis.

Authors:  Itsuki Anzai; Eiichi Tokuda; Atsushi Mukaiyama; Shuji Akiyama; Fumito Endo; Koji Yamanaka; Hidemi Misawa; Yoshiaki Furukawa
Journal:  Protein Sci       Date:  2017-02-12       Impact factor: 6.725

3.  The Disulfide Bond, but Not Zinc or Dimerization, Controls Initiation and Seeded Growth in Amyotrophic Lateral Sclerosis-linked Cu,Zn Superoxide Dismutase (SOD1) Fibrillation.

Authors:  Madhuri Chattopadhyay; Ekeoma Nwadibia; Cynthia D Strong; Edith Butler Gralla; Joan Selverstone Valentine; Julian P Whitelegge
Journal:  J Biol Chem       Date:  2015-10-28       Impact factor: 5.157

4.  Oxidation of the tryptophan 32 residue of human superoxide dismutase 1 caused by its bicarbonate-dependent peroxidase activity triggers the non-amyloid aggregation of the enzyme.

Authors:  Fernando R Coelho; Asif Iqbal; Edlaine Linares; Daniel F Silva; Filipe S Lima; Iolanda M Cuccovia; Ohara Augusto
Journal:  J Biol Chem       Date:  2014-09-18       Impact factor: 5.157

5.  Conformational Disorder of the Most Immature Cu, Zn-Superoxide Dismutase Leading to Amyotrophic Lateral Sclerosis.

Authors:  Yoshiaki Furukawa; Itsuki Anzai; Shuji Akiyama; Mizue Imai; Fatima Joy C Cruz; Tomohide Saio; Kenichi Nagasawa; Takao Nomura; Koichiro Ishimori
Journal:  J Biol Chem       Date:  2015-12-22       Impact factor: 5.157

6.  Altered thiol chemistry in human amyotrophic lateral sclerosis-linked mutants of superoxide dismutase 1.

Authors:  Carles Solsona; Thomas B Kahn; Carmen L Badilla; Cristina Álvarez-Zaldiernas; Juan Blasi; Julio M Fernandez; Jorge Alegre-Cebollada
Journal:  J Biol Chem       Date:  2014-08-04       Impact factor: 5.157

7.  Cellular Redox Systems Impact the Aggregation of Cu,Zn Superoxide Dismutase Linked to Familial Amyotrophic Lateral Sclerosis.

Authors:  Cristina Álvarez-Zaldiernas; Jun Lu; Yujuan Zheng; Hongqian Yang; Juan Blasi; Carles Solsona; Arne Holmgren
Journal:  J Biol Chem       Date:  2016-06-03       Impact factor: 5.157

8.  An Internal Disulfide Locks a Misfolded Aggregation-prone Intermediate in Cataract-linked Mutants of Human γD-Crystallin.

Authors:  Eugene Serebryany; Jaie C Woodard; Bharat V Adkar; Mohammed Shabab; Jonathan A King; Eugene I Shakhnovich
Journal:  J Biol Chem       Date:  2016-07-14       Impact factor: 5.157

9.  Dynamic disulfide exchange in a crystallin protein in the human eye lens promotes cataract-associated aggregation.

Authors:  Eugene Serebryany; Shuhuai Yu; Sunia A Trauger; Bogdan Budnik; Eugene I Shakhnovich
Journal:  J Biol Chem       Date:  2018-09-21       Impact factor: 5.157

10.  Disulfide scrambling in superoxide dismutase 1 reduces its cytotoxic effect in cultured cells and promotes protein aggregation.

Authors:  Lina Leinartaitė; Ann-Sofi Johansson
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.